期刊文献+

Acarbose Isolation with Gel Type Strong Acid Cation Exchange Resin: Equilibrium, Kinetic and Thermodynamic Studies 被引量:3

Acarbose Isolation with Gel Type Strong Acid Cation Exchange Resin: Equilibrium, Kinetic and Thermodynamic Studies
下载PDF
导出
摘要 Acarbose, a potent α-glucosidase inhibitor, is widely used as an oral anti-diabetic drug for the treatment of the type 2, non-insulin-dependent diabetes. In this work, a gel type strong acid cation exchange resin 001×4 was applied to isolate acarbose from fermentation broth. It was demonstrated that cation exchanger 001×4 displayed a large adsorption capacity and quick exchange rate for acarbose. The static adsorption equilibrium data were well fitted to the Langmuir equation. Column adsorption experiments demonstrated that high dynamic adsorption capacity was reached at bed height of 104.4 mm, feed flow rate of 1.0 ml·min 1and acarbose concentration of 4.0 mg·ml 1.Under the optimized conditions, the column chromatography packed with cation exchanger 001×4 recovered 74.3%(by mass) of acarbose from Actinoplanes utahensis ZJB-08196 fermentation broth with purity of 80.1%(by mass),demonstrating great potential in the practical applications in acarbose separation. Acarbose, a potentα-glucosidase inhibitor, is widely used as an oral anti-diabetic drug for the treatment of the type 2, non-insulin-dependent diabetes. In this work, a gel type strong acid cation exchange resin 001×4 was applied to isolate acarbose from fermentation broth. It was demonstrated that cation exchanger 001×4 displayed a large adsorption capacity and quick exchange rate for acarbose. The static adsorption equilibrium data were well fitted to the Langmuir equation. Column adsorption experiments demonstrated that high dynamic adsorption capacity was reached at bed height of 104.4 mm, feed flow rate of 1.0 ml·min-1 and acarbose concentration of 4.0 mg·ml-1. Under the optimized conditions, the column chromatography packed with cation exchanger 001×4 recovered 74.3%(by mass) of acarbose from Actinoplanes utahensis ZJB-08196 fermentation broth with purity of 80.1%(by mass), demonstrating great potential in the practical applications in acarbose separation.
出处 《Chinese Journal of Chemical Engineering》 SCIE EI CAS CSCD 2013年第10期1106-1113,共8页 中国化学工程学报(英文版)
基金 Supported by the National Basic Research Program of China(2011CB710800) National Special Program for Key Science and Technology of China(2008ZX09204-004)
关键词 强酸性阳离子交换树脂 阿卡波糖 平衡数据 凝胶型 分离 LANGMUIR方程 热力学 动力学 acarbose, separation, cation exchange, chromatography
  • 相关文献

参考文献28

  • 1Jermendy, G, "Can type 2 diabetes mellitus be considered prevent- able?", Diabetes Res. Clin. Pract., 68 (S1), S73-S81 (2005).
  • 2Chiasson, J.L., Josse, R.G, Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., "Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial", Lancet., 359 (9323), 2072-2077 (2002).
  • 3Hong, C., grim, K.H., Choi, B.T., Choi, G.S., Choi, Y.R., "Process for preparing acarbose with high purity", U.S. Pat., 6649755 (2003).
  • 4Rodriguez, J.E, De Lucas, A., Carmona, M., "Application of ion exchange to purify acarbose from fermentation broths", Biochem. Eng. J., 40, (1), 130 137 (2008).
  • 5Lange, RM., Rauenbusch, E., "Polymers for the purification of acarbose", U.S. Pat., 4666776 (1987).
  • 6Lange, EM., Rauenbusch, E., "Process for the purification of acar- bose with polymers", U.S. Pat., 4767850 (1988).
  • 7Lawton, C., "A process for the purification of acarbose", WO 99/07720 (1998).
  • 8Mihaljevic, K., Azaric, J., Bajie, B., "Acarbose purification process", U.S. Pat., 6734300 (2004).
  • 9Rauenbusch, E., "Highly pure acarbose", U.S. Pat., 4904769 (1990).
  • 10Wang, Y.J., Liu, L.L., Wang, Y.S., "'Actinoplanes utahensis ZJB-08196 fed-batch fermentation at elevated osmolality for enhancing acarbose production", Bioresour. Technol., 103 (1), 337-342 (2012).

同被引文献29

  • 1孙楠,周雪枫,胡宝祥,莫卫民.阿卡波糖的单扫描示波极谱法测定研究[J].浙江工业大学学报,2005,33(6):614-617. 被引量:1
  • 2何炳林 黄文强.离子交换与吸附[M].上海:上海科教出版社,1995..
  • 3Coniff R, Krol A. Acarbose: a review of US clinical experience [J]. Clinical Therapeutics, 1997, 19(1): 16-26.
  • 4Chiasson J L, Josse R G, Gomis R, et al. Acarbose for preven- tion of type 2 diabetes mellitus: the STOP-NIDDM randomised trial[J]. The Lancet, 2002, 359(9323): 2072-2077.
  • 5Chiasson J L, Josse R G, Gomis R, et al. Acarbose treatment and the risk of cardiovascular disease and hypertension in pa- tients with impaired glucose tolerance-the STOP-NIDDM trial [J]. JAMA-Journal of the American Medical Association, 2003, 290(4): 486-494.
  • 6Lebovitz It E. et-Glueosidase inhibitors as agents in the treat- ment of diabetes[J]. Diabetes Reviews, 1998, 6(2): 132-145.
  • 7Hemker M, Stratmann A, Goeke K, et al. Identification, cloning, expression, and characterization of the extracellular acarbose-modifying glycosyltransferase, AcbD, from Actinoplanes sp. Strain SE50[J]. Journal of Bacteriology, 2001, 183(15): 4484- 4492.
  • 8Wang Y J, Xue Y P, Wang Y S, et al. Analysis and determina- tion of anti-diabetes drug acarbose and its structural analogs[J]. Current Pharmaceutical Analysis, 2011, 7(1): 12-20.
  • 9European Pharmacopoeia Commission. European Pharmacopoeia 6.0[S]. 2008: 1089-1091.
  • 10Deak L, Keri V. Method for purification of aearbose. WO: 2002012256 AI[P]. 2002-02-14.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部